Glycoprotein 96 and α-Fetoprotein Cross-Linking Complexes Elicited Specific Antitumor Immunity
Authors:
- 1 June 2013
- journal article
- research article
- Published by SAGE Publications in Cancer Biotherapy and Radiopharmaceuticals
- Vol. 28 (5) , 406-414
Abstract
Hepatocellular carcinoma (HCC) is one of the most common malignant gastroenterological cancers over the world. α-fetoprotein (AFP) is an oncofetal protein produced during HCC development that could generate weaker and less reproducible antitumor protection, and it may serve as a target for immunotherapy. Therefore, it is imperative to enhance its immunogenicity and develop therapeutic vaccines to eliminate AFP-expressing tumors. In this study, by way of glutaraldehyde cross-linking, we constructed a potential therapeutic protein vaccine, glycoprotein 96 (gp96)/AFP. Our results demonstrated that AFP and gp96 synergistically exhibited significant increase in AFP-specific CD8+ T-cell responses and impressive cytotoxic antitumor effect against AFP-expressing tumors. Priming mice with the reconstructed vaccine, we elicited robust strong protective immunity. Our study suggests that tumor vaccine by cross-linking tumor antigen and gp96 is a promising approach to cancer therapy.Keywords
This publication has 33 references indexed in Scilit:
- Mycobacterial Heat Shock Proteins as Vaccines - A Model of Facilitated Antigen PresentationCurrent Molecular Medicine, 2007
- Antitumor immunity induced by DNA vaccine encoding alpha-fetoprotein/heat shock protein 70World Journal of Gastroenterology, 2004
- DNA vaccination with AFP-encoding plasmid DNA prevents growth of subcutaneous AFP-expressing tumors and does not interfere with liver regeneration in miceCancer Gene Therapy, 2002
- Cirrhotic Patients With or Without Hepatocellular Carcinoma Harbour AFP-Specific T-Lymphocytes That Can Be Activated in vitro by Human Alpha-FetoproteinScandinavian Journal of Gastroenterology, 2002
- Hepatocellular Carcinoma-Cause, Treatment and MetastasisWorld Journal of Gastroenterology, 2001
- Fine specificity analysis of an HLA-A2.1-restricted immunodominant T cell epitope derived from human α-fetoproteinMolecular Immunology, 2000
- Mouse α-fetoprotein–specific DNA-based immunotherapy of hepatocellular carcinoma leads to tumor regression in miceGastroenterology, 2000
- CD91: a receptor for heat shock protein gp96Nature Immunology, 2000
- The heat shock protein gp96: a receptor-targeted cross-priming carrier and activator of dendritic cellsCell Stress and Chaperones, 2000
- Hepatocellular carcinomaThe Lancet, 1999